GlassScriptPhysician profile
Alexa Arastoo
NPI 1245753284
$757.91
in general payments reported to CMS, 2019-2025
17 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.58 · 2021: $43.24 · 2022: $15.78 · 2023: $106 · 2024: $216 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573 · Long Term Medical Supply Or Device Loan: $84.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.84 |
| Long Term Medical Supply Or Device Loan | $84.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $202.31 | 2021-2025 | Epclusa |
| Novo Nordisk INC | $111.84 | 2024-2025 | Rybelsus, Ozempic |
| Baxter Healthcare | $84.47 | 2025 | Hillrom - Oae Hearing Screener |
| Exact Sciences Corporation | $74.99 | 2024-2025 | Cologuard Collection Kit |
| Abbvie INC. | $42.63 | 2023-2024 | Vraylar |
| Mylan Specialty L.P. | $34.78 | 2024 | Yupelri |
| Verity Pharmaceuticals INC. | $34.69 | 2024 | Tlando |
| Medtronic, INC. | $22.02 | 2024 | Intellis Adaptivestim |
| Hologic Sales and Service, LLC | $21.38 | 2024 | Third Wave, Thinprep 2000 Processor, Aptima |
| Abbott Laboratories | $19.11 | 2023 | Proclaim |
| Pfizer INC. | $19.00 | 2025 | |
| Merck Sharp & Dohme LLC | $17.39 | 2019 | |
| Lilly USA, LLC | $17.12 | 2025 | Mounjaro |
| Amgen INC. | $16.67 | 2025 | Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.32 | 2023 | Xifaxan |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12.10 | 2019 | |
| Genentech USA, INC. | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Arastoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.